A Real-world Claims Data Analysis of Meningococcal Serogroup B Vaccine Series Completion and Potential Missed Opportunities in the United States

In the United States, meningococcal serogroup B (MenB) vaccination is recommended for 16–23-year-olds based on shared clinical decision-making. We estimated series completion among individuals initiating MenB vaccination for the 2 available vaccines: MenB 4-component (MenB-4C, doses at 0 and ≥1 mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Packnett, Elizabeth R., Zimmerman, Nicole M., Kim, Gilwan, Novy, Patricia, Morgan, Laura C., Chime, Nnenna, Ghaswalla, Parinaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Vaccine Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920016/
https://www.ncbi.nlm.nih.gov/pubmed/35086118
http://dx.doi.org/10.1097/INF.0000000000003455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920016/
https://www.ncbi.nlm.nih.gov/pubmed/35086118
http://dx.doi.org/10.1097/INF.0000000000003455

Ejemplares similares